中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors

文献类型:期刊论文

作者Lu, Shuang; Zheng, Wei; Ji, Liyun; Luo, Qun; Hao, Xiang; Li, Xianchan; Wang, Fuyi
刊名EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
出版日期2013-03-01
卷号61页码:84-94
关键词Receptor Tyrosine Kinase Epidermal Growth Factor Receptor (Egfr) Anilinoquinazoline Inhibitor Docking Analysis
ISSN号0223-5234
DOI10.1016/j.ejmech.2012.07.036
英文摘要We report here the design and synthesis of a series of 4-anilinoquinazoline derivatives, of which 7 compounds were crystallographically characterized, as epidermal growth factor receptor (EGFR) inhibitors by modifications on the aniline ring or at the 6-alkoxy site of the 6,7-dimethoxy-4-anilinoquinazoline pharmacophore. The relative inhibition efficiency on EGFR of all as-prepared compounds were measured and ordered, and the IC50 values of nine highly active compounds were determined by ELISA. Docking studies indicated that all 4-anilinoquinazoline derivatives could be inserted into the ATP-binding pocket of the EGFR via indirect docking, and that the modifications at the 3'-position of the anilino group and 6-alkoxy site of the quinazoline ring have little interference with the formation of the two essential H-bonds between the N3 of the quinazoline ring and Thr766 through a water molecule, and the N1 of the quinazoline ring and N-H of Met769. The displacing of the phenyl at 4-position with pyridinyl dramatically reduces the activity of the quinazoline pharmacophore, the resulting derivative (10) being the least active compound. The docking results also showed that the formation of new H-bonds between the N-H of the ethylenediamine group linked to the 6-alkoxy site and Asp776/Cys773 in the binding pocket of EGFR makes compounds 19 (IC50= 12.1 +/- 1.6 nM) and 20 (IC50 = 13.6 +/- 0.8 nM) the most potent EGFR inhibitors in this class and worthy of further modification to obtain more potent anticancer compounds. (C) 2012 Elsevier Masson SAS. All rights reserved.
语种英语
WOS记录号WOS:000316537200008
出版者ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
源URL[http://ir.iccas.ac.cn/handle/121111/54839]  
专题中国科学院化学研究所
通讯作者Luo, Qun
作者单位Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, CAS Key Lab Analyt Chem Living Biosyst, Beijing 100190, Peoples R China
推荐引用方式
GB/T 7714
Lu, Shuang,Zheng, Wei,Ji, Liyun,et al. Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2013,61:84-94.
APA Lu, Shuang.,Zheng, Wei.,Ji, Liyun.,Luo, Qun.,Hao, Xiang.,...&Wang, Fuyi.(2013).Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,61,84-94.
MLA Lu, Shuang,et al."Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 61(2013):84-94.

入库方式: OAI收割

来源:化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。